Sidebar

[mostpost]

Originally Posted by Jeff P

Take a look at the data from Pfizer's clinical vaccine trial submitted to the FDA.

Imo, it literally could have been used to predict the results in the study from your post:

CH7 Israel National News | Nov 17 2021
FDA report finds all-cause mortality higher among vaccinated:
https://www.israelnationalnews.com/news/317091



PDF at the FDA.gov site:
https://www.fda.gov/media/151733/download

According to CH7 Israel National News, data submitted to the FDA from Pfizer's own clinical vaccine trial shows the following:

• 22,000 cohorts were given two doses of the Pfizer vaccine.

• 22,000 cohorts were given a placebo.

There were 3 COVID deaths among the study cohorts.

• 1 in the vaccinated group.

• 2 in the placebo group.

So twice as many COVID deaths among the placebo group.

Imo, based on that, the FDA committee voted to approve the Pfizer vaccine.

But that only gives you part of the big picture.

Buried on page 23 on the FDA's report of Pfizer's clinical vaccine trial data (link here) you can find the following:



• 21 all causes deaths among the vaccinated group.

• 17 all causes deaths among the placebo group.

So 23.5% higher all causes deaths among the vaccinated group. And the FDA claims the excess deaths in the vaccine group aren't related to vaccination.

I'm not buying that last part for a second.

The original table of all causes deaths submitted to the FDA by Pfizer (see the clickable thumbnail below) which I took a screenshot of but can no longer seem to find on the PDF at the FDA.gov site shows the following breakout of cardiac deaths:

• 4 cardiac arrests in the vaccinated group.
• 1 cardiac failure congestive in the vaccinated group.
• 1 cardio-respiratory arrest in the vaccinated group.
• 1 chronic obstructive pulmonary disease in the vaccinated group.

• 1 cardiac arrest in the placebo group.
• 0 cardiac failure congestive in the placebo group.
• 1 cardio-respiratory arrest in the placebo group.
• 0 chronic obstructive pulmonary disease in the placebo group.

So 7 cardiac deaths in the vaccinated group and 2 cardiac deaths in the placebo group.

Or 3.5 times the number of cardiac deaths in the vaccinated group vs. the placebo group.



-jp

.

Of these, ADRs of CVT were reported as 756 (0.07%) out of 1,154,023 cases for the mRNA-based COVID-19 vaccines (620 (0.05%) for BNT162b2 and 136 (0.01%) for mRNA-1273) and 757 (0.13%) out of 577,124 cases for the ChAdOx1 nCoV-19 vaccine.

The numbers above are from your link. For the Pfizer and Moderna vaccines, which are the vaccines in use in the United States, the incidence of CVT is under one tenth of one percent. An unvaccinated person is three times more likely to contract Covid and Four times more likely to die from it than a vaccinated person.
Clearly the reward greatly outweighs the risk.

CVT among hospitalized patients has a 2% mortality rate. But the vast, overwhelming majority of persons with CVT never need to be hospitalized. They are treated and cured long before.

Finally, this is what the authors of the study you referred to said about their study.
Our study has limitations. First, if the national drug-monitoring center of a country does not report ADRs, these cases will not be present in VigiBase. However, VigiBase includes rare ADRs and generalized ADR information from more than 130 countries. Second, VigiBase does not provide any validation of laboratory findings, radiologic information, or accuracy of diagnosis. Information on whether CVT occurred after the first or the second vaccine dose was also not included. Third, vaccine-induced immune thrombotic thrombocytopenia received major public attention after April 2021 [13], and this may have affected the increased reports of CVT cases after COVID-19 vaccination. Lastly, as mentioned above, it is difficult to directly compare outcome parameters, including death, between the different types of COVID-19 vaccines in VigiBase.